au.\*:("GUENTHNER T")
Results 1 to 25 of 27
Selection :
Selective inhibition and selective induction of multiple microsomal epoxide hydrolasesGUENTHNER, T. M.Biochemical pharmacology. 1986, Vol 35, Num 5, pp 839-845, issn 0006-2952Article
Characterization of multiple epoxide hydrolase activities in mouse liver nuclear envelopeGUENTHNER, T. M.Biochemical pharmacology. 1986, Vol 35, Num 19, pp 3261-3266, issn 0006-2952Article
Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogsLUO, G; GUENTHNER, T. M.Drug metabolism and disposition. 1996, Vol 24, Num 9, pp 1020-1027, issn 0090-9556Article
INHIBITION OF BINDING OF BENZO (A) PYRENE METABOLITES TO NUCLEAR DNA BY GLUTATHIONE AND GLUTATHIONE S-TRANSFERASE BHESSE S; JERNSTROEM B; MARTINEZ M et al.1980; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1980; VOL. 94; NO 2; PP. 612-617; BIBL. 16 REF.Article
Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole : conjugation with glutathioneGANG LUO; GUENTHNER, T. M.Drug metabolism and disposition. 1994, Vol 22, Num 5, pp 731-737, issn 0090-9556Article
Identification and characterization of a new epoxide hydrolase from mouse liver microsomesGUENTHNER, T. M; OESCH, F.The Journal of biological chemistry (Print). 1983, Vol 258, Num 24, pp 15054-15061, issn 0021-9258Article
COMPARISON OF HEPATIC MICROSOMAL DRUG-METABOLIZING SYSTEMS FROM RATS RED CRUDE AND PURIFIED DIETSABBOTT V; DELORIA L; GUENTHNER T et al.1976; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1976; VOL. 4; NO 3; PP. 215-222; BIBL. 18 REF.Article
Hydrolysis of teh 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolasesLUO, G; QATO, K; GUENTHNER, T. M et al.Drug metabolism and disposition. 1992, Vol 20, Num 3, pp 440-445, issn 0090-9556Article
Direct measurement of melphalan conjugation with glutathione : studies with human melanoma cells and mammalian liverGUENTHNER, T. M; WHALEN, R; JEVTOVIC-TODOROVIC, V et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 260, Num 3, pp 1331-1336, issn 0022-3565Article
32P-postlabeling analysis of adducts formed between DNA and safrole 2',3'-epoxide : absence of adduct formation in vivoQATO, M. K; GUENTHNER, T. M.Toxicology letters. 1995, Vol 75, Num 1-3, pp 201-207, issn 0378-4274Article
Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine : correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitroJEVTOVIC-TODOROVIC, V; GUENTHNER, T. M.Biochemical pharmacology. 1992, Vol 44, Num 7, pp 1383-1393, issn 0006-2952Article
Multiple epoxide hydrolases in human lungGUENTHNER, T. M; KARNEZIS, T. A.Drug metabolism and disposition. 1986, Vol 14, Num 2, pp 208-213, issn 0090-9556Article
Sensitivity of human melanoma cells to melphalan cytotoxicity by adriamycin and carmustineJEVTORIC-TODOROVIC, V; GUENTHNER, T. M.Journal of cancer research and clinical oncology. 1991, Vol 117, Num 4, pp 313-320, issn 0171-5216Article
In vitro synthesis of fluorescein monoglucuronideGUENTHNER, T. M; BLAIR, N. P.Pharmacology. 1988, Vol 37, Num 5, pp 341-348, issn 0031-7012Article
Importance of the route of administration for genetic differences in benzo[a] pyrene-induced in utero toxicity and teratogenicityLEGRAVEREND, C; GUENTHNER, T. M; NEBERT, D. W et al.Teratology (Philadelphia, PA). 1984, Vol 29, Num 1, pp 35-47, issn 0040-3709Article
Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycleGUENTHNER, T. M; DANLIN CAI; WALLIN, R et al.Biochemical pharmacology. 1998, Vol 55, Num 2, pp 169-175, issn 0006-2952Article
Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIAWHEELER, C. W; WRIGHTON, S. A; GUENTHNER, T. M et al.Biochemical pharmacology. 1992, Vol 44, Num 1, pp 183-186, issn 0006-2952Article
Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomesWHEELER, C. W; SANG SHIN PARK; GUENTHNER, T. M et al.Molecular pharmacology. 1990, Vol 38, Num 5, pp 634-643, issn 0026-895X, 10 p.Article
Production of monospecific antiserum to a cytosolic epoxide hydrolase from human liverQATO, M. K; GLOMB REINMUND, S; GUENTHNER, T. M et al.Biochemical pharmacology. 1990, Vol 39, Num 2, pp 293-300, issn 0006-2952Article
The effects of metyrapone, chalcone epoxide, benzil, clotrimazole and related compounds on the activity of microsomal epoxide hydrolase in situ, in purified form and in reconstituted systems towards different substratesSEIDEGARD, J; DEPIERRE, J. W; GUENTHNER, T. M et al.European journal of biochemistry (Print). 1986, Vol 159, Num 2, pp 415-423, issn 0014-2956Article
Vitamin K epoxide reductase activity in the metabolism of epoxidesLIPTAY-REUTER, I; DOSE, K; GUENTHNER, T et al.Biochemical pharmacology. 1985, Vol 34, Num 15, pp 2617-2620, issn 0006-2952Article
An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitroPIRMOHAMED, M; KIEETERINGHAM, N. R; GUENTHNER, T. M et al.Biochemical pharmacology. 1992, Vol 43, Num 8, pp 1675-1682, issn 0006-2952Article
Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolitesHJELLE, J. T; GUENTHNER, T. M; BELL, K et al.Toxicology (Amsterdam). 1990, Vol 60, Num 3, pp 211-222, issn 0300-483XArticle
Compartmentation of glutathione : Implications for the study of toxicity and diseaseSMITH, C. V; JONES, D. P; GUENTHNER, T. M et al.Toxicology and applied pharmacology. 1996, Vol 140, Num 1, pp 1-12, issn 0041-008XArticle